Contrast-enhanced ultrasounds are an effective complementary tool in following up patients who undergo endovascular repair for abdominal aortic aneurysm.
Contrast-enhanced ultrasounds are an effective complementary tool in following up patients who undergo endovascular repair for abdominal aortic aneurysm, according to a study published in the journal Radiology.
Endovascular repair for abdominal aortic aneurysm (EVAR) is performed to place an endograft into the vessel to bypass the weakened area in the aorta. Currently, routine surveillance of the stent, to watch for endoleaks that raise the risk of an aneurysm sac rupture, is done by CT angiography. However there is concern regarding the use of CTs because of related ionizing radiation and potential kidney damage from the contrast agent.
Researchers from the Hospital Clinic in Barcelona, Spain, evaluated 35 patients who underwent CT angiography and an ultrasound with a second-generation contrast agent. The smaller microbubbles in the new agent do not pass through the cells that line the inner surface of the blood vessel walls. The exams were performed at one- and six-month follow up and every year thereafter, for a total of 126 performed studies.
According to Rosa Gilabert, MD, PhD, from the Hospital Clinic, in determining the presence of an endoleak, the contrast-enhanced ultrasound had a sensitivity of 97 percent, a specificity of 100 percent, and an accuracy of 99 percent. It enabled correct classification of 26 to 33 endoleaks and did not miss any that were clinically important.
“These results support that contrast-enhanced ultrasound can be integrated into EVAR follow-up,” Dr. Gilabert said.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.